Pramipexole - CISMeF

Preferred Label : Pramipexole;

MeSH definition : A benzothiazole derivative and dopamine agonist with antioxidant properties that is used in the treatment of PARKINSON DISEASE and RESTLESS LEGS SYNDROME.;

MeSH synonym : 4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazole-diamine; Pramipexol; 2-Amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole;

MeSH hyponym : Pramipexol, (R)-isomer; SND919CL2x; SND-919CL2x; SND 919; KNS760704; KNS-760704; Pramipexole Hydrochloride Monohydrate;

Related MeSH term : 2 Amino 6 propylaminotetrahydrobenzothiazole;

MeSH CAS label : 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (S)-;

MeSH Related Number : 104632-25-9 (Anhydrous di-HCl); 104632-26-0 (Pramipexol); 104632-28-2 (Dexpramipexole); 134624-04-7 (( -)-isomer); 134624-05-8 (di-HBr); 3D867NP06J; 4R2HD0M28N; WI638GUS96;

Wikipedia link : https://en.wikipedia.org/wiki/Pramipexole;

UNII : 83619PEU5T;

Details

Origin ID

D000077487;

UMLS CUI

C0074710;

ATC code(s)
- pramipexole [ATC Code]
ATC code(s)
- pramipexole [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Pramipexole dihydrochloride (substance) [SNOMED CT concept]
- Pramipexole dihydrochloride monohydrate (substance) [SNOMED CT concept]
Manual BTNT mappings - CISMeF
- Pramipexole dihydrochloride (substance) [SNOMED CT concept]
MeSH indexing information
- receptors, dopamine d1 [MeSH Descriptor]
- receptors, dopamine d2 [MeSH Descriptor]
- restless legs syndrome [MeSH Descriptor]
Pharmacological action(s)
- antioxidants [MeSH Descriptor]
- antiparkinson agents [MeSH Descriptor]
- dopamine agonists [MeSH Descriptor]
Record concept(s)
- 2-Amino-6-propylaminotetrahydrobenzothiazole [MeSH concept]
- 6,7-tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate [MeSH concept]
- Pramipexole Dihydrochloride [MeSH concept]
- Pramipexole Dihydrochloride Anhydrous [MeSH concept]
- SND-919 [MeSH concept]
- Sifrol [MeSH concept]
- mirapex [MeSH concept]
- pramipexol dihydrobromide, (+-)-isomer [MeSH concept]
- pramipexol dihydrochloride, (S)-isomer [MeSH concept]
- pramipexol, (+-)-isomer [MeSH concept]
- pramipexole [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients